Skip to main content
OpenTrials

Clinical trial condition

Idiopathic Pulmonary Fibrosis

Explore clinical trials studying Idiopathic Pulmonary Fibrosis. Study availability and eligibility vary by location and protocol.

330 public trials 44 recruiting studies
Refine in advanced search Browse all conditions

Idiopathic Pulmonary Fibrosis trial results

Completed

Safety, Tolerability and PK of Nintedanib in Combination With Pirfenidone in IPF

NCT02579603

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Western CT Medical Group, P.C. Danbury, Connecticut, United States
  • Tulane University Hospital and Clinic New Orleans, Louisiana, United States
  • Minnesota Lung Center Minneapolis, Minnesota, United States
  • The Lung Research Center, LLC Chesterfield, Missouri, United States
View all 23 locations
View Trial Details
Completed

Observational Study to Evaluate Disease Course and Outcomes in Patients Treated With Esbriet (Pirfenidone) for Idiopathic Pulmonary Fibrosis (IPF) in Canada

NCT02552849

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • South Health Campus/Alberta Health Services/ University of Calgary Calgary, Alberta, Canada
  • Edmonton Respiratory Consultants & Edmonton Sleep Lab Edmonton, Alberta, Canada
  • Grey Nuns Community Hospital Edmonton, Alberta, Canada
  • Synergy Respiratory Care Sherwood Park, Alberta, Canada
View all 26 locations
View Trial Details
Completed

A Study of Oral Vismodegib in Combination With Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis

NCT02648048

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Scripps Clinic La Jolla, California, United States
  • Central Florida Pulmonary Group, PA Orlando, Florida, United States
  • Suburban Lung Associates Elk Grove, Illinois, United States
  • Medical Consultants, PC ; Pulmonary Muncie, Indiana, United States
View all 15 locations
View Trial Details
Completed

Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary Fibrosis

NCT01214187

Conditions
Fibrosis, Idiopathic Pulmonary Fibrosis, Lung Diseases, +5 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • University of Illinois Chicago Chicago, Illinois, United States
  • University of Chicago Chicago, Illinois, United States
  • Tulane University New Orleans, Louisiana, United States
View Trial Details

Related conditions